Your browser doesn't support javascript.
loading
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma.
Shannan, B; Matschke, J; Chauvistré, H; Vogel, F; Klein, D; Meier, F; Westphal, D; Bruns, J; Rauschenberg, R; Utikal, J; Forschner, A; Berking, C; Terheyden, P; Dabrowski, E; Gutzmer, R; Rafei-Shamsabadi, D; Meiss, F; Heinzerling, L; Zimmer, L; Livingstone, Elisabeth; Váraljai, Renáta; Hoewner, A; Horn, S; Klode, J; Stuschke, M; Scheffler, B; Marchetto, A; Sannino, G; Grünewald, T G P; Schadendorf, D; Jendrossek, V; Roesch, A.
Afiliação
  • Shannan B; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Matschke J; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical School, Germany.
  • Chauvistré H; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Vogel F; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Klein D; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical School, Germany.
  • Meier F; Skin Cancer Center National Center for Tumor Diseases, Department of Dermatology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Germany.
  • Westphal D; Skin Cancer Center National Center for Tumor Diseases, Department of Dermatology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Germany.
  • Bruns J; Skin Cancer Center National Center for Tumor Diseases, Department of Dermatology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Germany.
  • Rauschenberg R; Skin Cancer Center National Center for Tumor Diseases, Department of Dermatology, Medical Faculty and University Hospital Carl Gustav Carus, TU Dresden, Germany.
  • Utikal J; Skin Cancer Unit German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
  • Forschner A; Department of Dermatology, Center for Dermatooncology, University Hospital Tübingen, Germany.
  • Berking C; Department of Dermatology and Allergy, University Hospital of Munich, Munich, Germany.
  • Terheyden P; Department of Dermatology, University of Luebeck, Luebeck, Germany.
  • Dabrowski E; Department of Dermatology, Klinikum Ludwigshafen, Ludwigshafen, Germany.
  • Gutzmer R; Skin Cancer Centre, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
  • Rafei-Shamsabadi D; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Meiss F; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Heinzerling L; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Zimmer L; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Livingstone E; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Váraljai R; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Hoewner A; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Horn S; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Klode J; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Stuschke M; Department of Radiotherapy, West German Cancer Center, University Hospital, University of Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Essen, Germany.
  • Scheffler B; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Marchetto A; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, Germany.
  • Sannino G; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, Germany.
  • Grünewald TGP; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany.
  • Jendrossek V; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical School, Germany.
  • Roesch A; Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Germany. Electronic address: alexander.roesch@uk-essen.de.
Eur J Cancer ; 109: 137-153, 2019 03.
Article em En | MEDLINE | ID: mdl-30721788
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Radioterapia / Neoplasias Encefálicas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Radioterapia / Neoplasias Encefálicas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha